Cationic Polymer Suspension for Continuous Liquid Formulation

The patent applies preliminary action by pre-forming a stable suspension of cationic acrylic polymer particles in a suitable liquid medium before incorporation into the final formulation. This pre-suspension step prevents the swelling issue during continuous manufacturing, as the polymer remains in a stable suspended state rather than swelling into a viscous mass. The suspension is prepared in advance with appropriate suspending agents and processing conditions that maintain particle stability throughout the continuous manufacturing process.

The patent applies parameter changes by carefully selecting and optimizing the solvent system parameters to achieve both continuous dosing capability and formulation compatibility. The solvent choice and concentration are specifically adjusted to maintain polymer solubility for continuous dosing while ensuring compatibility with other formulation components. This may involve adjusting solvent polarity, viscosity, or composition ratios to balance the competing requirements of dosing feasibility and formulation stability.

The patent applies continuity of useful action by transitioning from batch processing to continuous manufacturing processes. The polymer suspension is continuously fed and processed through the formulation system, eliminating the start-stop nature of batch operations. This continuous flow approach ensures consistent mixing conditions, polymer distribution, and formulation quality across all production, removing the variability inherent in batch-to-batch processing while maintaining the capability to add polymer effectively.